(Q51570673)

English

Intense nonpharmacological intervention in subjects with multiple cardiovascular risk factors: decreased fasting insulin levels but only a minor effect on plasma plasminogen activator inhibitor activity.

scientific article published in April 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9550533

Intense nonpharmacological intervention in subjects with multiple cardiovascular risk factors: decreased fasting insulin levels but only a minor effect on plasma plasminogen activator inhibitor activity. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9550533

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Göran Hallmans

4

object named as

Hallmans G

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

author name string

Lindahl B

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9550533

Nilsson TK

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9550533

Asplund K

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9550533

publication date

1 April 1998

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9550533

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9550533

47

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9550533

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9550533

384-390

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9550533

Haemostatic factors in coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Essential hypertension, metabolic disorders, and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Insulin resistance syndrome and fibrinolytic activity: the northern Sweden MONICA study.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Increased blood fibrinolytic activity after physical exercise: comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Effects of maximal exercise and venous occlusion on fibrinolytic activity in physically active and inactive men

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Fasting blood coagulation and fibrinolysis of young adults unchanged by reduction in dietary fat content

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Effects on fibrinolytic activity of corn oil and a fish oil preparation enriched with omega-3-polyunsaturated fatty acids in a long-term study

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Reduced plasminogen activator inhibitor activity in high consumers of fruits, vegetables and root vegetables

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Normal plasminogen activator inhibitor levels at long-term follow-up after jejuno-ileal bypass surgery in morbidly obese individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Quantification of exercise capability and evaluation of physical capacity in man

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Evaluation of a maximal predictive cycle ergometer test of aerobic power

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

A short cycle ergometer test to predict maximal workload and maximal oxygen uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

FIBRINOLYSIS IN OBESITY

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Decreased plasminogen activator inhibitor-1 activity in newly diagnosed type 2 diabetic patients following dietary modification

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Genetic factors determining thrombosis and fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Constitutive biosynthesis of plasminogen activator inhibitor type-1 (PAI-1) by cultured human aortic endothelial cells independent of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990047-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0026-0495(98)90047-6

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9550533

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9550533

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51570673&oldid=1517927575"